Ana S. Mora

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial.

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial.

Journal: British journal of haematology
Published: November 01, 2024

Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination.

Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination.

Journal: Vaccines
Published: August 01, 2024

Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trial.

Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trial.

Journal: EJHaem
Published: March 07, 2024

Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study.

Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study.

Journal: Trials
Published: February 26, 2024

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: September 21, 2022

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.

Journal: Transfusion
Published: February 17, 2022

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.

Journal: Blood
Published: May 22, 2020

The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England.

The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England.

Journal: Transfusion medicine (Oxford, England)
Published: April 17, 2020

The application of a haemorrhage assessment tool in evaluating control of bleeding in a pilot trauma haemorrhage trial.

The application of a haemorrhage assessment tool in evaluating control of bleeding in a pilot trauma haemorrhage trial.

Journal: Transfusion medicine (Oxford, England)
Published: May 01, 2019

Randomized Trial of Platelet-Transfusion Thresholds in Neonates.

Randomized Trial of Platelet-Transfusion Thresholds in Neonates.

Journal: The New England journal of medicine
Published: November 03, 2018

Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial.

Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial.

Journal: Critical care (London, England)
Published: March 13, 2018

Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.

Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.

Journal: Lancet (London, England)
Published: May 10, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026